1. Home
  2. ETJ vs DNA Comparison

ETJ vs DNA Comparison

Compare ETJ & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETJ
  • DNA
  • Stock Information
  • Founded
  • ETJ 2007
  • DNA 2008
  • Country
  • ETJ United States
  • DNA United States
  • Employees
  • ETJ N/A
  • DNA N/A
  • Industry
  • ETJ Finance Companies
  • DNA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ETJ Finance
  • DNA Health Care
  • Exchange
  • ETJ Nasdaq
  • DNA Nasdaq
  • Market Cap
  • ETJ 603.7M
  • DNA 731.1M
  • IPO Year
  • ETJ N/A
  • DNA N/A
  • Fundamental
  • Price
  • ETJ $8.99
  • DNA $12.58
  • Analyst Decision
  • ETJ
  • DNA Hold
  • Analyst Count
  • ETJ 0
  • DNA 2
  • Target Price
  • ETJ N/A
  • DNA $9.50
  • AVG Volume (30 Days)
  • ETJ 175.6K
  • DNA 1.6M
  • Earning Date
  • ETJ 01-01-0001
  • DNA 08-07-2025
  • Dividend Yield
  • ETJ 8.30%
  • DNA N/A
  • EPS Growth
  • ETJ N/A
  • DNA N/A
  • EPS
  • ETJ N/A
  • DNA N/A
  • Revenue
  • ETJ N/A
  • DNA $230,815,000.00
  • Revenue This Year
  • ETJ N/A
  • DNA N/A
  • Revenue Next Year
  • ETJ N/A
  • DNA $13.73
  • P/E Ratio
  • ETJ N/A
  • DNA N/A
  • Revenue Growth
  • ETJ N/A
  • DNA 25.21
  • 52 Week Low
  • ETJ $7.20
  • DNA $5.00
  • 52 Week High
  • ETJ $8.47
  • DNA $16.85
  • Technical
  • Relative Strength Index (RSI)
  • ETJ 53.08
  • DNA 51.58
  • Support Level
  • ETJ $8.90
  • DNA $10.96
  • Resistance Level
  • ETJ $9.04
  • DNA $12.81
  • Average True Range (ATR)
  • ETJ 0.08
  • DNA 1.07
  • MACD
  • ETJ 0.00
  • DNA -0.11
  • Stochastic Oscillator
  • ETJ 64.00
  • DNA 50.08

About ETJ Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest

Eaton Vance Risk-Managed Diversified Equity Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The group invests in various sectors such as financials, healthcare, consumer discretionary, consumer staples, industrials, energy, utilities, telecommunication services, and materials. Under normal market conditions, the Fund's investment program consists of majorly owning a diversified portfolio of common stocks and employing a variety of options strategies.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: